Page last updated: 2024-10-25

clioquinol and Remission, Spontaneous

clioquinol has been researched along with Remission, Spontaneous in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gimenez-Camarasa, JM1
Garcia-Calderon, P1
de Moragas, JM1

Other Studies

1 other study available for clioquinol and Remission, Spontaneous

ArticleYear
Lymphocyte transformation test in fixed drug eruption.
    The New England journal of medicine, 1975, Apr-17, Volume: 292, Issue:16

    Topics: Aminopyrine; Aspirin; Cells, Cultured; Clioquinol; Drug Eruptions; Humans; Lymphocyte Activation; Ox

1975